Jerry DeCiccio
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jerry DeCiccio
Jerry DeCiccio is recorded as CFO at Sigyn Therapeutics, Inc. (SIGY). Sigyn Therapeutics, Inc. reported in an 8-K filed March 7, 2025 that Jerry DeCiccio retired as Chief Financial Officer, effective February 26, 2025. Sigyn Therapeutics, Inc. reported in an 8-K filed December 12, 2023 that Jerry DeCiccio was appointed Chief Financial Officer, effective December 6, 2023.
“On February 26, 2025, our Chief Financial Officer, Mr. Gerald DeCiccio provided us a notice of retirement, effective immediately.”
“The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-06–present
-
2023-12-06–2025-02-26
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sigyn Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- James Joyce CEO, Chairman, Board Member
- Craig Roberts CTO, Board Member
- Christopher Wetzel Board Member
- Jim Dorst Board Member
- Michael Ryan Board Member
- Richa Nand Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.